• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

Nymox Pharmaceutical Corp

+ Add to Watchlist

NY2:GR

0.303 EUR 0.061 16.76%

As of 15:17:33 ET on 12/23/2014.

Snapshot for Nymox Pharmaceutical Corp (NY2)

Open: 0.333 Day's Range: 0.301 - 0.334 Volume: 0
Previous Close: 0.364 52wk Range: 0.216 - 4.951 1-Yr Rtn: -93.12%

Stock Chart for NY2

No chart data available.
  • NY2:GR 0.301
  • 1D
  • 1M
  • 1Y
0.364
Interactive NY2 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NY2

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -
Est. PEG Ratio -
Market Cap (M EUR) 10.62
Shares Outstanding (M) 35.05
30 Day Average Volume 5,163
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NY2

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for NY2

Nymox Pharmaceutical Corporation is a biopharmaceutical company. The Company is engaged in therapeutics in development for enlarged prostate (BPH), E. coli, Alzheimer's disease and other indications and diagnostics for tobacco exposure, Alzheimer's disease and other conditions.

Paul AverbackChairman/President/CEO/FounderAndre MonetteChief Financial Officer
Jack GemmellCIO/General CounselBrian DoyleSenior Mgr:Global Sales & Mktg
More Company Profile & Key Executives for NY2

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil